Sarah Danson Selected Research

Sarah Danson Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 07/2002
10	Melanoma (Melanoma, Malignant) 01/2022 - 07/2002
7	Neoplasm Metastasis (Metastasis) 12/2020 - 10/2004
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2014 - 05/2004
6	Mesothelioma 06/2022 - 09/2013
5	Malignant Mesothelioma 06/2022 - 09/2013
4	Disease Progression 06/2022 - 10/2015
4	Lung Neoplasms (Lung Cancer) 10/2020 - 06/2005
3	Bone Resorption 10/2020 - 10/2004
3	Breast Neoplasms (Breast Cancer) 09/2015 - 10/2002
2	Carcinoma (Carcinomatosis) 01/2021 - 08/2003
2	Thrombocytopenia (Thrombopenia) 05/2019 - 04/2009
1	Pleural Effusion (Pleural Effusions) 01/2022
1	Nausea 01/2020
1	Pain (Aches) 12/2019
1	Neutropenia 05/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Brain Neoplasms (Brain Tumor) 10/2015
1	Primary Myelofibrosis (Myelosclerosis) 02/2015
1	Lymphoma (Lymphomas) 04/2009
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2009
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2009
1	Circulating Neoplastic Cells 04/2009
1	Hypophosphatemia 04/2009
1	Carcinogenesis 08/2007
1	Bronchogenic Carcinoma 06/2005
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2005

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 08/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2004
4	PlatinumIBA 06/2022 - 08/2007
3	CytokinesIBA 01/2022 - 07/2002
3	IpilimumabIBA 07/2021 - 10/2015
3	Gemcitabine FDA Link 01/2021 - 08/2003
3	Carboplatin (JM8)FDA LinkGeneric 12/2020 - 08/2003
3	Pharmaceutical PreparationsIBA 12/2019 - 07/2002
3	ErbB Receptors (EGF Receptor)IBA 08/2007 - 01/2005
2	NivolumabIBA 11/2021 - 04/2018
2	Monoclonal AntibodiesIBA 07/2021 - 01/2018
2	MethyltransferasesIBA 01/2021 - 12/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2019 - 05/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 09/2015
2	Docetaxel (Taxotere)FDA Link 11/2014 - 04/2009
2	Gefitinib (Iressa)FDA Link 08/2007 - 01/2005
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2005 - 08/2003
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	AntibodiesIBA 07/2021
1	guadecitabineIBA 01/2021
1	Dacarbazine (DIC)FDA LinkGeneric 12/2020
1	Denosumab FDA Link 10/2020
1	Zoledronic Acid (Zometa)FDA Link 10/2020
1	LigandsIBA 10/2020
1	NF-kappa B (NF-kB)IBA 10/2020
1	QuercetinIBA 07/2020
1	fisetinIBA 07/2020
1	navitoclaxIBA 07/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Folic Acid AntagonistsIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	STA 9090IBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 12/2019
1	collagen type I trimeric cross-linked peptideIBA 12/2019
1	src-Family KinasesIBA 12/2019
1	saracatinibIBA 12/2019
1	Analgesics (Analgesic Drugs)IBA 12/2019
1	N-Methylaspartate (NMDA)IBA 12/2019
1	Radium-223IBA 05/2019
1	AsbestosIBA 04/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 01/2018
1	AlbuminsIBA 10/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2015
1	Methotrexate (Mexate)FDA LinkGeneric 02/2015
1	Janus KinasesIBA 02/2015
1	SurvivinIBA 11/2014
1	LY 2181308IBA 11/2014
1	Antisense OligonucleotidesIBA 11/2014
1	Bortezomib (Velcade)FDA Link 09/2013
1	SmokeIBA 12/2012
1	X-Linked Inhibitor of Apoptosis ProteinIBA 04/2009
1	Messenger RNA (mRNA)IBA 04/2009
1	AEG 35156IBA 04/2009
1	EnzymesIBA 04/2009
1	rofecoxib (Vioxx)FDA Link 08/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2007
1	docosahexaenoyl-paclitaxelIBA 11/2006
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2005
1	Tyrosine Kinase InhibitorsIBA 01/2005
1	Collagen Type I (Type I Collagen)IBA 10/2004

Therapy/Procedure

13	Therapeutics 06/2022 - 01/2005
10	Drug Therapy (Chemotherapy) 06/2022 - 01/2005
4	Immunotherapy 01/2022 - 07/2002
1	Oncolytic Virotherapy 01/2022
1	Neoadjuvant Therapy 01/2021
1	Palliative Care (Palliative Therapy) 01/2012
1	Intravenous Infusions 04/2009
1	Aftercare (After-Treatment) 11/2006
1	Radiotherapy 01/2005